Conference Details - Registration
Continuing Education Information
Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Seventh International Symposium on Supportive Care in Oncology: Cancer Management in the Era of Targeted Agents
The Ritz-Carlton New York, Battery Park
New York, NY
February 27-28, 2009
Online registration is now closed. Please register for this conference on-site.
For registration assistance, please email CustomerSupport@CancerLearning.com, or call (888) 949-0045.
Pricing
| Register After Wednesday, Dec 31, 2008 |
|
| Physicians | $295.00 |
| Fellows, Pharmacists, Nurses, Other | $195.00 |
| Industry* | $995.00 |
Registration fees include continental breakfast and syllabus materials.
A cancellation fee of 25% will be assessed on refunds requested prior to January 23, 2009, and a 50% cancellation fee will be applied to refunds requested between January 23, 2009, and February 13, 2009. No refunds will be made after February 13, 2009. There is no charge for substitution.
* INDUSTRY is defined by PER as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical. Industry registrations cannot be processed online. To request attendance at a congress, registration can be submitted via fax, phone, or e-mail. For more information, e-mail us at info@cancerlearning.com
Physicians’ Education Resource fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (888) 949-0045.
Educational Grants
An educational grant for this activity was provided by:
- Amgen
- Merck Oncology
- AstraZeneca
- Cephalon Oncology
- Eisai, Inc.
- Genentech BioOncology